← FDA Drug Approvals (Drugs@FDA)

NAVITRUX

NDA · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2026-06-24

Drug application

FDA Application #

NDA220436

Application type

New Drug Application

Brand name

NAVITRUX

Generic name

FOSAPREPITANT

Active ingredients

FOSAPREPITANT DIMEGLUMINE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AVYXA HOLDINGS

Manufacturer

AVYXA Pharma, LLC

First approval

2026-06-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown